Evidence map›Paper›PMID 39048363›Full record

ArticleInternal medicine (Tokyo, Japan)2025

Cardiac Malignant Lymphoma with Diffuse Extension to the Left Ventricle.

Daichi Terunuma, Masanobu Miura, Ko Teshima, Yuta Kagaya, Hiroki Saito, Kenjiro Sato, Masanori Kanazawa, Masateru Kondo, Hideaki Endo, Kazunori Murai and 2 more

Abstract readCase Reports
In one paragraph

Article in Internal medicine (Tokyo, Japan), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Daichi TerunumaDepartment of Cardiology, Iwate Prefectural Central Hospital, Japan.
Masanobu MiuraDepartment of Cardiology, Iwate Prefectural Central Hospital, Japan.
Ko TeshimaDepartment of Hematology, Iwate Prefectural Central Hospital, Japan.
Yuta KagayaDepartment of Cardiology, Iwate Prefectural Central Hospital, Japan.
Hiroki SaitoDepartment of Cardiology, Iwate Prefectural Central Hospital, Japan.
Kenjiro SatoDepartment of Cardiology, Iwate Prefectural Central Hospital, Japan.
Masanori KanazawaDepartment of Cardiology, Iwate Prefectural Central Hospital, Japan.
Masateru KondoDepartment of Cardiology, Iwate Prefectural Central Hospital, Japan.
Hideaki EndoDepartment of Cardiology, Iwate Prefectural Central Hospital, Japan.
Kazunori MuraiDepartment of Hematology, Iwate Prefectural Central Hospital, Japan.
Tsutomu SakumaDepartment of Pathology, Iwate Prefectural Central Hospital, Japan.
Akihiro NakamuraDepartment of Cardiology, Iwate Prefectural Central Hospital, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Malignant cardiac lymphoma is rare and commonly involves nodules on the right side of the heart. We herein report a case of malignant cardiac lymphoma with diffuse extension into the left ventricle. The patient was a woman in her 60s who complained of dyspnea and malaise. Echocardiography revealed left ventricular hypertrophy (LVH), and magnetic resonance imaging revealed diffuse contrast enhancement on delayed contrast. Cardiac catheterization and a myocardial biopsy suggested heart failure due to cardiac malignant lymphoma, and diastolic dysfunction was mild despite LVH. The patient underwent chemotherapy, and her cardiac function improved and was maintained.

Indexed as

Heart NeoplasmsHeart VentriclesLymphomaLymphoma, Large B-Cell, DiffuseAntineoplastic Combined Chemotherapy ProtocolsEchocardiographyFemaleHumansHypertrophy, Left VentricularMagnetic Resonance ImagingMiddle Agedcardiac catheterizationheart ventricleshypertrophylymphoma

Identifiers

PMID39048363
PMCPMC11949656

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.